Bio-Techne (MEX:TECH) Marketable Securities: MXN0 Mil (As of Mar. 2026)


MEX:TECH Bio-Techne Corp MEX:TECH
83 GF Score
Price MXN1,090.00
GF Value MXN1,109.72
! 8 Warning Signs
View Full Analysis

What is Bio-Techne Marketable Securities?

Bio-Techne MEX:TECH 83 Marketable Securities is MXN0 Mil as of Mar. 2026. GuruFocus rates MEX:TECH with a GF Score™ of 83/100 and a GF Value™ of MXN1,109.72. The stock has 8 warning signs investors should review.

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. Bio-Techne's Marketable Securities for the quarter that ended in Mar. 2026 was MXN0 Mil.

Bio-Techne's annual Marketable Securities declined from Jun. 2023 (MXN407 Mil) to Jun. 2024 (MXN20 Mil) and declined from Jun. 2024 (MXN20 Mil) to Jun. 2025 (MXN0 Mil).

Bio-Techne  (MEX:TECH) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".

Bio-Techne Marketable Securities Related Terms

Bio-Techne Marketable Securities Historical Data

* Premium members only.

The historical data trend for Bio-Techne's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bio-Techne Marketable Securities Chart

Bio-Techne Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
Marketable Securities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 646.21 1,498.03 406.98 19.64 0.00

Bio-Techne Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Marketable Securities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
MEX:TECH
83GF Score
Bio-Techne Corp MEX:TECH
Marketable Securities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Bio-Techne Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

Frequently Asked Questions Learn more about Marketable Securities →
What does a Marketable Securities of MXN0 Mil mean?
Bio-Techne (MEX:TECH) has a Marketable Securities of MXN0 Mil as of Mar. 2026. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on Bio-Techne and its competitors.
Is Bio-Techne's Marketable Securities too high?
Bio-Techne's current Marketable Securities is MXN0 Mil. Overall, Bio-Techne has a GF Score™ of 83/100, reflecting its overall financial health beyond just this single metric.
How does Bio-Techne's Marketable Securities compare to ARWR and CYTK?
Bio-Techne's Marketable Securities of MXN0 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Marketable Securities for a Biotechnology company?
A good Marketable Securities depends on the Biotechnology industry context. However, Marketable Securities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Marketable Securities mean?
A high Marketable Securities can signal that a stock is expensive relative to its fundamentals. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on Bio-Techne and its competitors. Bio-Techne's current Marketable Securities is MXN0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bio-Techne stock overvalued right now?
Bio-Techne (MEX:TECH) has a current Marketable Securities of MXN0 Mil. The stock's GF Value™ is MXN1,109.72, compared to a current price of MXN1,090.00 — trading 1.8% below its estimated fair value. The current Marketable Securities is MXN0 Mil. Bio-Techne's overall GF Score™ is 83/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Marketable Securities calculated?
Marketable Securities is calculated from a company's financial statements. For Bio-Techne (MEX:TECH), the current Marketable Securities is MXN0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Bio-Techne (MEX:TECH) Overvalued in 2026?

Based on GuruFocus' analysis, Bio-Techne stock appears to be undervalued. The current stock price of MXN1,090.00 is trading 1.8% below its estimated GF Value™ of MXN1,109.72.

Key valuation signals for MEX:TECH:

  • Marketable Securities: MXN0 Mil
  • GF Value™: MXN1,109.72 vs. price of MXN1,090.00 (1.8% below fair value)
  • GF Score™: 83/100 with 8 warning signs

No single metric tells the full story. See the MEX:TECH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Bio-Techne Business Description

Address 614 McKinley Place N.E., Minneapolis, MN, USA, 55413
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (about 75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of the world accounting for the remaining 5%.
83GF Score

Get the complete analysis for MEX:TECH

Marketable Securities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN1,090.00
Price
MXN1,109.72
GF Value